Paradox Immunotherapeutics (Investment)

Funding Details
Awarder
Inbox
Date Award
February 25, 2025
Vertical
Pharmaceuticals
Funding URL
View Funding Page

Company Info
Organizations Involved
SymBiosis Capital Management
Founders
Dr. Natalie Galant
Company Description
Paradox Immunotherapeutics is a pharmaceutical company that develops treatments for patients suffering from rare amyloid diseases.
Market
Biotechnology
Location
Toronto, Canada

Links
Back to Home Back to Pharmaceuticals Deals View Funding Announcement